One of the triazole antifungal agents that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis.
ITRACONAZOLE POWDER
Structure
Product Description
Details |
|
|---|---|
Chemical Name |
ITRACONAZOLE POWDER |
IUPAC Name |
(2R,4S)-rel-1-(Butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one |
CAS Number |
84625-61-6 |
Molecular Formula |
C35H38CI2N8O4 |
Synonyms |
R51211;Orungal;Sempera;SPORANOX;Itrizole;Canditral;Sporamelt;TRIASPORIN;AKOS 92112;Oricomzole |
Application |
For the treatment of the following fungal infections in immunocompromised and non-immunocompromised patients: pulmonary and extrapulmonary blastomycosis, histoplasmosis, aspergillosis, and onychomycosis. |